Position in VRTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$468,867
+$61,297 QoQ
Shares Held
1,050
+16.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Ancora Advisors LLC holds $4,503,700 across 42 Biotechnology names. VRTX ranks #4 (10.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | OMER |
Omeros Corp
|
115,000 | $1,214,400 | |
| 2 | GLSI |
Greenwich LifeSciences, Inc.
|
37,500 | $900,750 | |
| 3 | CRVS |
Corvus Pharmaceuticals, Inc.
|
54,768 | $801,255 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
1,050 | $468,867 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
4,016 | $191,041 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
2,391 | $179,540 | |
| 7 | IBRX |
ImmunityBio, Inc.
|
20,000 | $153,400 | |
| 8 | SRPT |
Sarepta Therapeutics, Inc.
|
4,316 | $93,916 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $468,867 | 1,050 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $407,570 | 899 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $327,802 | 837 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $372,187 | 836 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $406,279 | 838 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $324,978 | 807 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $375,319 | 807 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $376,850 | 804 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $368,684 | 882 | Shares | Sole | 2024-05-16 | |
| 2023-12-31 | $304,760 | 749 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $288,276 | 829 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $272,026 | 773 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $238,823 | 758 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $153,342 | 531 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $127,976 | 442 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $129,059 | 458 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $97,863 | 375 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $54,900 | 250 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $33,375 | 184 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $22,179 | 110 | Shares | Sole | 2021-11-12 | |
| 2021-03-31 | $23,637 | 110 | Shares | Sole | 2021-11-12 | |
| 2020-12-31 | $25,997 | 110 | Shares | Sole | 2021-11-12 | |
| 2020-09-30 | $9,796 | 36 | Shares | Sole | 2021-11-12 | |
| 2020-06-30 | $1,741 | 6 | Shares | Sole | 2021-11-12 | |
| 2020-03-31 | $1,427 | 6 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||